Search Results - "Zhao, Sean Z."

Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice by WOLFE, Frederick, MICHAUD, Kaleb, BURKE, Thomas A, ZHAO, Sean Z

“…OBJECTIVE: To compare COX-2-specific inhibitor therapy with conventional nonspecific nonsteroidal antiinflammatory drugs (NS NSAID), and investigate the effect…”
Get full text

Dose-response relationship between opioid use and adverse effects after ambulatory surgery by Zhao, Sean Z, Chung, Frances, Hanna, David B, Raymundo, Anna L, Cheung, Raymond Y, Chen, Connie

“…This health outcomes analysis based on data from a randomized, double-blind, placebo-controlled trial determined dose-response relationship between opioid use…”
Get full text

Psychometric evaluation of the 12-item short-form health survey (SF-12) in osteoarthritis and rheumatoid arthritis clinical trials by Gandhi, Sanjay K., Warren Salmon, J., Zhao, Sean Z., Lambert, Bruce L., Gore, Prasanna R., Conrad, Kendon

“…Background: The psychometric properties of the 12-Item Short-Form Health Survey (SF-12), a subset of the Medical Outcomes Study 36-Item Short-Form Health…”
Get full text

A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre safety database by Zhao, Sean Z., Reynolds, Matthew W., Lefkowith, James, Whelton, Andrew, Arellano, Felix M.

“…Background: Two isoforms of cyclooxygenase (COX) have been identified, both of them inhibited by traditional nonsteroidal anti-inflammatory drugs (NSAIDs)…”
Get full text

P-448: Patient burden of weight gain and blood pressure increase among RA patients using celecoxib, rofecoxib, and non-specific NSAIDs by Wolfe, Frederick, Michaud, Kaleb, Zhao, Sean Z.

“…Purpose: Nonspecfic NSAIDs (NS NSAIDs) and COX-2 specific inhibitors are used by 66% of RA patients; the use of these drugs may be accompanied by potential,…”
Get full text

Incidence of outpatient physician claims for upper gastrointestinal symptoms among new users of celecoxib, ibuprofen, and naproxen in an insured population in the United States by Goldstein, Jay L, Zhao, Sean Z, Burke, Thomas A, Palmer, Ryan, von Allmen, Heather, Henderson, Scott C

“…The aim of this study was to compare the risk of outpatient medical claims for UGI symptoms among new users of celecoxib versus ibuprofen, and naproxen. The…”
Get full text

Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs by Zhao, Sean Z., Wentworth, Chuck, Burke, Thomas A., Makuch, Robert W.

“…Purpose To compare RA and OA patients' time‐to‐switch after newly initiating treatment with three most commonly used non‐specific (NS)‐NSAIDs and two COX‐2…”
Get full text

Risk of Acute Liver Injury in Patients with Diabetes by Huerta, Consuelo, Zhao, Sean Z., Rodríguez, Luis Alberto García

“…Study Objectives. To estimate the incidence of acute liver injury in patients with diabetes and compare it with the corresponding incidence in the general…”
Get full text

Comparison of upper gastrointestinal symptoms between users of celecoxib, ibuprofen, and naproxen in a U.S. insured population by Goldstein, Jay L., Zhao, Sean Z., Burke, Thomas A., von Allmen, Heather, Henderson, Scott C.

Get full text

Arthritis care: Comparison of physicians' and patients' views by Lambert, Bruce L., Butin, Danielle N., Moran, Diane, Zhao, Sean Z., Carr, Barbara C., Chen, Connie, Kizis, F.J.

“…Objectives: To understand the expressed needs of physicians and their patients with respect to arthritis care, identify areas of agreement and disagreement in…”
Get full text

Urinary Antispasmodic Use and the Risks of Ventricular Arrhythmia and Sudden Death in Older Patients by Wang, Philip S., Levin, Raisa, Zhao, Sean Z., Avorn, Jerry

“…The introduction of new medications to treat overactive bladder has resulted in a significant increase in the number of individuals with this condition who use…”
Get full text

Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors by Zhao, Sean Z, Burke, Thomas A, Whelton, Andrew, von Allmen, Heather, Henderson, Scott C

“…To determine the incremental cost of blood pressure (BP) destabilization among patients with stable hypertension who newly initiate therapy with celecoxib,…”
Get full text

Patient Perception of the Burden of Weight Gain and Blood Pressure Increase Among RA Patients Using Celecoxib, Rofecoxib, and Non-specific NSAIDs by Wolfe, Frederick, Michaud, Kaleb, Zhao, Sean Z

“…Nonsteroidal anti-inflammatory medications (NSAIDs) may be accompanied by clinically important renal side effects. We compared the rate of reported side…”
Get full text

Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice by Zhao, Sean Z, Burke, Thomas A, Whelton, Andrew, von Allmen, Heather, Henderson, Scott C

“…To evaluate the baseline cardiovascular (CV) risk of hypertensive patients newly starting cyclooxygenase (COX)-2-specific inhibitors (celecoxib or rofecoxib)…”
Get full text

Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors by Zhao, Sean Z, Burke, Thomas A, Whelton, Andrew, von Allmen, Heather, Henderson, Scott C

“…To determine the costs of heart failure in hypertensive patients receiving celecoxib, rofecoxib, and nonspecific nonsteroidal anti-inflammatory drugs (NSAIDs)…”
Get full text

Case of cholestatic hepatitis with celecoxib did not fulfil international criteria by Arellano, Felix M, Zhao, Sean Z, Reynolds, Matthew W

“…[...]the number of expected cases of cholestatic hepatitis should range between 208 and 260…”
Get full text

Length of hospital stay and cost of Staphylococcus and Streptococcus infections among hospitalized patients by Zhao, Sean Z., Dodge, William E., Spalding, William, Barr, Charles E., Li, Jim Z.

“…Background:Staphylococcus (Staph) and Streptococcus (Strep) infections are important causes of morbidity and mortality worldwide. The economic burden of these…”
Get full text

Determining minimally important changes in generic and disease‐specific health‐related quality of life questionnaires in clinical trials of rheumatoid arthritis by Kosinski, Mark, Zhao, Sean Z., Dedhiya, Seema, Osterhaus, Jane T., Ware, John E.

“…Objective To define clinically meaningful changes in 2 widely used health‐related quality of life (HQL) instruments in studies of patients with rheumatoid…”
Get full text

Patient burden of weight gain and blood pressure increase among RA patients using celecoxib, rofecoxib, and non-specific NSAIDs by Wolfe, Frederick, Michaud, Kaleb, Zhao, Sean Z.

Get full text

Evaluation of the Functional Status Aspects of Health-Related Quality of Life of Patients with Osteoarthritis Treated with Celecoxib by Zhao, Sean Z., McMillen, James I., Markenson, Joseph A., Dedhiya, Seema D., Zhao, William W., Osterhaus, Jane T., Yu, Shawn S.

“…Study Objective. To evaluate the functional status of patients with signs and symptoms of osteoarthritis of the knee after treatment with celecoxib compared…”
Get full text